Literature DB >> 8683379

Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.

P Vaidya1, Y Kawarada, T Higashiguchi, T Yoshida, T Sakakura, R Yatani.   

Abstract

The expression of epidermal growth factor receptor (EGFR), c-erbB-2, and c-erbB-3 was examined immunohistochemically in 57 cases of periampullary carcinoma. The percentage of Ki-67-positive cells was also examined in the same tissue, to determine the relationship between the expression of the members of the type I growth factor receptor family and cell proliferation. In carcinoma of the head of pancreas, the percentage of cases with overexpression of c-erbB-3 was significantly higher than with overexpression of c-erbB-2 and EGFR. In contrast, in lower bile duct carcinoma and carcinoma of the ampulla of Vater, the percentages of cases with overexpression of c-erbB-2 was greater than with overexpression of other growth factor receptors. A higher percentage of cases with overexpression of c-erbB-3 in pancreatic head carcinoma and overexpression of c-erbB-2 in carcinoma of the ampulla of Vater was found in Ki-67 antigen-positive cases. Moreover, the overexpression of c-erb-3 in pancreatic head carcinoma, c-erb-2 in ampulla of Vater carcinoma, and Ki-67 in both carcinomas was found to be associated with poor patient outcome. These results demonstrate that different members of the type I growth factor receptor family are overexpressed in different carcinomas of the periampullary region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683379     DOI: 10.1002/(SICI)1096-9896(199602)178:2<140::AID-PATH450>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

Review 1.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

Review 2.  HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Authors:  Salvatore Galdy; Angela Lamarca; Mairéad G McNamara; Richard A Hubner; Chiara A Cella; Nicola Fazio; Juan W Valle
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

3.  Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation.

Authors:  Jian Hao; Xue Yang; Xiu-Li Ding; Lei-Ming Guo; Cui-Hong Zhu; Wei Ji; Tong Zhou; Xiong-Zhi Wu
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

4.  The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.

Authors:  Angela Lamarca; Salvatore Galdy; Jorge Barriuso; Sharzad Moghadam; Elizabeth Beckett; Jane Rogan; Alison Backen; Catherine Billington; Mairéad G McNamara; Richard A Hubner; Angela Cramer; Juan W Valle
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.